Skip to content

The efficacy of brief dynamic interpersonal therapy on patients with depressive disorder: Protocol for a prospective, multicenter randomized controlled Trial

The efficacy of brief dynamic interpersonal therapy on patients with depressive disorder: Protocol for a prospective, multicenter randomized controlled Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800016970
Enrollment
Unknown
Registered
2018-07-05
Start date
2018-09-01
Completion date
Unknown
Last updated
2018-07-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Major Depressive Disorder

Interventions

1:medication as usual
2:medication assisted DIT
3:medication assisted general supportive psychotherapy

Sponsors

Clinical Center of Shanghai Mental Health Center
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: To be eligible, participants need to be between the ages of 18-65 years; meet DSM-5 criteria for MDD based on the Mini International Neuropsychiatry Interview (ref), administered by psychiatrists with at least associate chief level, with a score =18 on the 17-item Hamilton Depression Rating Scale (HAMD-17); have completed at least primary school education (i.e., =6 years of education); be antidepressant drug na?ve or discontinued antidepressant medications at least 8 weeks prior to the screen visit; have not received psychotherapy in the last 6 months; provide written informed consent.

Exclusion criteria

Exclusion criteria: Exclusion criteria include a severe concurrent medical condition; significant visual and auditory deficits; lifetime history of psychosis or bipolar disorder; history of substance use disorders in the last 24 months,; history of psychotic features of affective disorder; high suicide risk; personality disorders; and intellectual disability. Other psychiatric comorbidities will be allowed so long as the MDD is the primary and predominant disorder.

Design outcomes

Primary

MeasureTime frame
efficacy;

Secondary

MeasureTime frame
response rate;remission rate;

Countries

China

Contacts

Public ContactJianyin Qiu

Shanghai Mental Health Center

jianyin_qiu@163.com+86 13524376330

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 26, 2026